Oyouni AAA (2023) Human papillomavirus in Cancer: infection, Disease Transmission, and Progress in vaccines. J Infect Public Health 16(4):626–631. https://doi.org/10.1016/j.jiph.2023.02.014

Article  PubMed  Google Scholar 

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

Article  PubMed  CAS  Google Scholar 

de Martel C, Plummer M, Vignat J, Franceschi S (2017) Worldwide Burden of Cancer Attributable to HPV by Site, Country and HPV Type. Int J Cancer 141(4):664–670. https://doi.org/10.1002/ijc.30716

Article  PubMed  PubMed Central  CAS  Google Scholar 

Martel C (2020) Global burden of Cancer Attributable to infections in 2018: a Worldwide Incidence Analysis. Lancet Glob Health 8(2):e180–e190. https://doi.org/10.1016/S2214-109X(19)30488-7. GeorgesD.Bray, F.; Ferlay, J.; Clifford, G. M.

Article  PubMed  Google Scholar 

M B, Jj K, K C, M D, G G, Ea B, D M, Kt S, É B, Mc B, S S, C R, A K, M C, Dtn N, Ma S, Jf L, M J, M A, F B, E F, F E, Pjn B, N B, R H (2020) Impact of HPV Vaccination and Cervical Screening on Cervical Cancer Elimination: a comparative modelling analysis in 78 low-income and Lower-Middle-Income Countries. Lancet 395(10224). https://doi.org/10.1016/S0140-6736(20)30068-4

Cervical cancer. https://www.who.int/news-room/fact-sheets/detail/cervical-cancer (accessed 2024-04-02)

Cohen PA, Jhingran A, Oaknin A, Denny L (2019) Cervical Cancer. Lancet Lond Engl 393(10167):169–182. https://doi.org/10.1016/S0140-6736(18)32470-X

Article  Google Scholar 

Lin Y, Lin W-Y, Lin T-W, Tseng Y-J, Wang Y-C, Yu J-R, Chung C-R, Wang H-Y (2023) Trend of HPV Molecular Epidemiology in the Post-vaccine era: a 10-Year study. Viruses 15(10):2015. https://doi.org/10.3390/v15102015

Article  PubMed  PubMed Central  CAS  Google Scholar 

Perkins RB, Wentzensen N, Guido RS, Schiffman M (2023) Cervical Cancer screening: a review. JAMA 330(6):547–558. https://doi.org/10.1001/jama.2023.13174

Article  PubMed  CAS  Google Scholar 

US Preventive Services Task Force, Curry SJ, Krist AH, Owens DK, Barry MJ, Caughey AB, Davidson KW, Doubeni CA, Epling JW, Kemper AR, Kubik M, Landefeld CS, Mangione CM, Phipps MG, Silverstein M, Simon MA, Tseng C-W, Wong JB (2018) Screening for cervical Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 320(7):674–686. https://doi.org/10.1001/jama.2018.10897

Article  Google Scholar 

Fontham ETH, Wolf AMD, Church TR, Etzioni R, Flowers CR, Herzig A, Guerra CE, Oeffinger KC, Shih Y-CT, Walter LC, Kim JJ, Andrews KS, DeSantis CE, Fedewa SA, Manassaram-Baptiste D, Saslow D, Wender RC, Smith RA (2020) Cervical Cancer screening for individuals at average risk: 2020 Guideline Update from the American Cancer Society. CA Cancer J Clin 70(5):321–346. https://doi.org/10.3322/caac.21628

Article  PubMed  Google Scholar 

Bouvard Véronique; Wentzensen Nicolas; Mackie Anne; Berkhof Johannes; Brotherton Julia; Giorgi-Rossi Paolo; Kupets Rachel; Smith Robert; Arrossi Silvina; Bendahhou Karima; Canfell Karen, Chirenje Z, Mike; Chung MH; del Pino Marta; de Sanjosé Silvia; Elfström Miriam; Franco Eduardo, Herrington L, Simon C (2021) Murillo Raúl; Sangrajrang Suleeporn; Sankaranarayanan Rengaswamy; Saraiya Mona; Schiffman Mark; Zhao Fanghui; Arbyn Marc; Prendiville Walter; Indave Ruiz Blanca I.; Mosquera-Metcalfe Isabel; Lauby-Secretan Béatrice. The IARC Perspective on Cervical Cancer Screening. N. Engl. J. Med. 385 (20), 1908–1918. https://doi.org/10.1056/NEJMsr2030640

Maver PJ, Poljak M, Primary HPV-B (2020) Cervical Cancer screening in Europe: implementation status, challenges, and future plans. Clin Microbiol Infect 26(5):579–583. https://doi.org/10.1016/j.cmi.2019.09.006

Article  PubMed  CAS  Google Scholar 

Kyrgiou M, Arbyn M, Bergeron C, Bosch FX, Dillner J, Jit M, Kim J, Poljak M, Nieminen P, Sasieni P, Kesic V, Cuzick J, Gultekin M (2020) Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic Oncology (ESGO) and the European Federation of Colposcopy (EFC). Br J Cancer 123(4):510–517. https://doi.org/10.1038/s41416-020-0920-9

Article  PubMed  PubMed Central  Google Scholar 

Bhatla N, Singhal S, Primary HPV, Screening for Cervical Cancer (2020) Best Pract Res Clin Obstet Gynaecol 65:98–108. https://doi.org/10.1016/j.bpobgyn.2020.02.008

Article  PubMed  Google Scholar 

Burd EM (2020) Human Papillomavirus Laboratory Testing: the changing paradigm. Clin Microbiol Rev 29(2):291–319. https://doi.org/10.1128/cmr.00013-15

Article  CAS  Google Scholar 

Williams J, Kostiuk M, Biron VL (2022) Molecular detection methods in HPV-Related cancers. Front Oncol 12:864820. https://doi.org/10.3389/fonc.2022.864820

Article  PubMed  PubMed Central  CAS  Google Scholar 

Poljak M, Cuschieri K, Alemany L, Vorsters A (2023) Testing for human papillomaviruses in urine, blood, and oral specimens: an update for the Laboratory. J Clin Microbiol 61(8):e01403–e01422. https://doi.org/10.1128/jcm.01403-22

Article  PubMed  PubMed Central  CAS  Google Scholar 

Shin HY, Lee B, Hwang SH, Lee DO, Sung NY, Park JY, Jun JK (2019) Evaluation of satisfaction with three different cervical Cancer screening modalities: Clinician-Collected Pap Test vs. HPV Test by Self-Sampling vs. HPV Test by urine sampling. J Gynecol Oncol 30(5):e76. https://doi.org/10.3802/jgo.2019.30.e76

Article  PubMed  PubMed Central  CAS  Google Scholar 

Pathak N, Dodds J, Zamora J, Khan K (2014) Accuracy of urinary human papillomavirus testing for Presence of Cervical HPV: systematic review and Meta-analysis. Bmj-Br Med J 349:g5264. https://doi.org/10.1136/bmj.g5264

Article  CAS  Google Scholar 

Huntington S, Puri Sudhir K, Schneider V, Sargent A, Turner K, Crosbie EJ, Adams EJ (2023) Two self-sampling strategies for HPV Primary Cervical Cancer Screening compared with clinician-collected sampling: an economic evaluation. BMJ Open 13(6):e068940. https://doi.org/10.1136/bmjopen-2022-068940

Article  PubMed  PubMed Central  Google Scholar 

Vorsters A, Micalessi I, Bilcke J, Ieven M, Bogers J, Van Damme P (2012) Detection of human papillomavirus DNA in urine. A review of the literature. Eur J Clin Microbiol Infect Dis 31(5):627–640. https://doi.org/10.1007/s10096-011-1358-z

Article  PubMed  CAS  Google Scholar 

Terada N, Matsuura M, Kurokawa S, Nishimura Y, Tamate M, Isoyama K, Yamazaki S, Shimada H, Suzuki M, Tabuchi Y, Teramoto M, Saito T (2022) Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples. Int J Clin Oncol 27(11):1742–1749. https://doi.org/10.1007/s10147-022-02238-1

Article  PubMed  Google Scholar 

Martinelli M, Giubbi C, Di Meo ML, Perdoni F, Musumeci R, Leone BE, Fruscio R, Landoni F, Cocuzza CE (2023) Accuracy of human papillomavirus (HPV) testing on urine and vaginal self-samples compared to clinician-collected cervical sample in women referred to Colposcopy. Viruses 15(9):1889. https://doi.org/10.3390/v15091889

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hentschel AE, van den Helder R, van Trommel NE, van Splunter AP, van Boerdonk RAA, van Gent MDJM, Nieuwenhuijzen JA, Steenbergen RD (2021) M. The origin of Tumor DNA in urine of Urogenital Cancer patients: local shedding and Transrenal Excretion. Cancers 13(3):535. https://doi.org/10.3390/cancers13030535

Article  PubMed  PubMed Central  CAS  Google Scholar 

Tranberg M, Jensen JS, Bech BH, Andersen B (2020) Urine Collection in Cervical Cancer Screening - Analytical comparison of two HPV DNA assays. BMC Infect Dis 20(1):926. https://doi.org/10.1186/s12879-020-05663-7

Article  PubMed  PubMed Central  CAS  Google Scholar 

Zou K, Huang Y, Li Z (2022) Prevention and treatment of human papillomavirus in men benefits both men and women. Front Cell Infect Microbiol 12:1077651. https://doi.org/10.3389/fcimb.2022.1077651

Article  PubMed  PubMed Central  Google Scholar 

L B, G A, J R, L A, M A, Ar G, Le M, N B, M T (2023) Global and Regional estimates of Genital Human Papillomavirus Prevalence among men: a systematic review and Meta-analysis. Lancet Glob Health 11(9). https://doi.org/10.1016/S2214-109X(23)00305-4

F K, P W, A B, N D-M, W Q, C B, C H (2016) Comparison of urine samples and Penile swabs for detection of human papillomavirus in HIV-Negative Dutch men. Sex Transm Infect 92(6). https://doi.org/10.1136/sextrans-2015-052054

Bissett SL, Howell-Jones R, Swift C, De Silva N, Biscornet L, Parry JV, Saunders NA, Nathan M, Soldan K, Szarewski A, Cuzick J, Beddows S (2011) Human papillomavirus genotype detection and viral load in Paired Genital and urine samples from both females and males. J Med Virol 83(10):1744–1751. https://doi.org/10.1002/jmv.22167

Article  PubMed  CAS  Google Scholar 

H Y, Zy L, F L, Lj L, M L, Lx X, Ly Y (2023) Comparison of Urine and Genital Samples for Detecting Human Papillomavirus (HPV) in Clinical Patients. Obstet. Gynecol. Int. 2023. https://doi.org/10.1155/2023/7483783

H X, Y Y, W G, Js S, S H, L D, X Z, Q P, Y Q, F Z (2020) Comparison of the performance of paired urine and cervical samples for Cervical Cancer Screening in Screening Population. J Med Virol 92(2). https://doi.org/10.1002/jmv.25597